{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:50:26Z","timestamp":1767916226227,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Hist"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10735-019-09826-y","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T07:02:35Z","timestamp":1555916555000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND)"],"prefix":"10.1007","volume":"50","author":[{"given":"Sphamandla","family":"Ntshangase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sipho","family":"Mdanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik G.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thavendran","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-1779","authenticated-orcid":false,"given":"Sooraj","family":"Baijnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"9826_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1517\/14740338.6.2.147","volume":"6","author":"G Arendt","year":"2007","unstructured":"Arendt G, de Nocker D, von Giesen H-J, Nolting T (2007) Neuropsychiatric side effects of efavirenz therapy. Expert Opin Drug Saf 6:147\u2013154. \n                    https:\/\/doi.org\/10.1517\/14740338.6.2.147","journal-title":"Expert Opin Drug Saf"},{"key":"9826_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1212\/WNL.43.10.2099","volume":"43","author":"EH Aylward","year":"1993","unstructured":"Aylward EH, Henderer J, McArthur JC, Brettschneider P, Harris G, Barta P, Pearlson G (1993) Reduced basal ganglia volume in HIV-1-associated dementia Results from quantitative neuroimaging. Neurology 43:2099\u20132099. \n                    https:\/\/doi.org\/10.1212\/WNL.43.10.2099","journal-title":"Neurology"},{"key":"9826_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10735-015-9634-3","volume":"46","author":"S Baijnath","year":"2015","unstructured":"Baijnath S, Naiker S, Shobo A, Moodley C, Adamson J, Ngcobo B, Bester LA, Singh S et al (2015) Evidence for the presence of clofazimine and its distribution in the healthy mouse brain. J Mol Histol 46:439\u2013442. \n                    https:\/\/doi.org\/10.1007\/s10735-015-9634-3","journal-title":"J Mol Histol"},{"key":"9826_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1128\/AAC.04215-14","volume":"59","author":"AE Basson","year":"2015","unstructured":"Basson AE, Rhee S-Y, Parry CM, El-Khatib Z, Charalambous S, De Oliveira T, Pillay D, Hoffmann C et al (2015) Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 59:960\u2013971. \n                    https:\/\/doi.org\/10.1128\/aac.04215-14","journal-title":"Antimicrob Agents Chemother"},{"key":"9826_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/ppa.s28797","volume":"7","author":"C Bernardini","year":"2013","unstructured":"Bernardini C, Maggiolo F (2013) Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera\u2122\/Eviplera\u2122) in the treatment of HIV infection. Patient Prefer Adherence 7:531\u2013542. \n                    https:\/\/doi.org\/10.2147\/ppa.s28797","journal-title":"Patient Prefer Adherence"},{"key":"9826_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/bmc.2765","volume":"27","author":"L Burugula","year":"2012","unstructured":"Burugula L, Pilli NR, Makula A, Lodagala DS, Kandhagatla R (2012) Liquid chromatography-tandem mass spectrometric assay for the non-nucleoside reverse transcriptase inhibitor rilpivirine in human plasma. Biomed Chromatogr 27:172\u2013178. \n                    https:\/\/doi.org\/10.1002\/bmc.2765","journal-title":"Biomed Chromatogr"},{"key":"9826_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bcp.2012.03.024","volume":"84","author":"E Clercq De","year":"2012","unstructured":"De Clercq E (2012) Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era. Biochem Pharmacol 84:241\u2013248. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2012.03.024","journal-title":"Biochem Pharmacol"},{"key":"9826_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.02.017","author":"B Dogan-Topal","year":"2019","unstructured":"Dogan-Topal B, Li W, Schinkel AH, Beijnen JH, Sparidans RW (2019) Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry. J Chromatogr B. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2019.02.017","journal-title":"J Chromatogr B"},{"key":"9826_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0140-6736(91)92786-2","volume":"337","author":"IP Everall","year":"1991","unstructured":"Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119\u20131121. \n                    https:\/\/doi.org\/10.1016\/0140-6736(91)92786-2","journal-title":"Lancet"},{"key":"9826_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2334-11-356","volume":"11","author":"M Gissl\u00e9n","year":"2011","unstructured":"Gissl\u00e9n M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 11:356. \n                    https:\/\/doi.org\/10.1186\/1471-2334-11-356","journal-title":"BMC Infect Dis"},{"key":"9826_CR11","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1021\/acs.analchem.5b04603","volume":"88","author":"P K\u00e4llback","year":"2016","unstructured":"K\u00e4llback P, Nilsson A, Shariatgorji M, Andr\u00e9n PE (2016) msIQuant: quantitation software for mass spectrometry imaging enabling fast access, visualization, and analysis of large data sets. Anal Chem 88:4346\u20134353. \n                    https:\/\/doi.org\/10.1021\/acs.analchem.5b04603","journal-title":"Anal Chem"},{"key":"9826_CR12","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/cercor\/bhr285","volume":"22","author":"KJ Kallianpur","year":"2012","unstructured":"Kallianpur KJ, Kirk GR, Sailasuta N, Valcour V, Shiramizu B, Nakamoto BK, Shikuma C (2012) Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex 22:2065\u20132075. \n                    https:\/\/doi.org\/10.1093\/cercor\/bhr285","journal-title":"Cereb Cortex"},{"key":"9826_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S1359-6446(05)03620-2","volume":"10","author":"WA Korfmacher","year":"2005","unstructured":"Korfmacher WA (2005) Foundation review: principles and applications of LC\u2013MS in new drug discovery. Drug Discov Today 10:1357\u20131367. \n                    https:\/\/doi.org\/10.1016\/S1359-6446(05)03620-2","journal-title":"Drug Discov Today"},{"key":"9826_CR14","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1128\/AAC.01401-13","volume":"57","author":"JM Lade","year":"2013","unstructured":"Lade JM, Avery LB, Bumpus NN (2013) Human biotransformation of the nonnucleoside reverse transcriptase inhibitor rilpivirine and a cross-species metabolism comparison. Antimicrob Agents Chemother 57:5067\u20135079. \n                    https:\/\/doi.org\/10.1128\/aac.01401-13","journal-title":"Antimicrob Agents Chemother"},{"key":"9826_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E et al (2008) Validation of the cns penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. JAMA Neurol 65:65\u201370. \n                    https:\/\/doi.org\/10.1001\/archneurol.2007.31","journal-title":"JAMA Neurol"},{"key":"9826_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbr.2007.11.021","volume":"188","author":"RJ Melrose","year":"2008","unstructured":"Melrose RJ, Tinaz S, Castelo JMB, Courtney MG, Stern CE (2008) Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 188:337\u2013347. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2007.11.021","journal-title":"Behav Brain Res"},{"key":"9826_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","volume":"378","author":"J-M Molina","year":"2011","unstructured":"Molina J-M, Cahn P, Grinsztejn B, Lazzarin A, Mills A, Saag M, Supparatpinyo K, Walmsley S et al (2011) Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet 378:238\u2013246. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(11)60936-7","journal-title":"Lancet"},{"key":"9826_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","volume":"20","author":"DJ Moore","year":"2006","unstructured":"Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL et al (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20:879\u2013887","journal-title":"AIDS"},{"key":"9826_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00498254.2017.1375168","volume":"48","author":"S Ntshangase","year":"2017","unstructured":"Ntshangase S, Shobo A, Kruger HG, Asperger A, Niemeyer D, Arvidsson PI, Govender T, Baijnath S (2017) The downfall of TBA-354: a possible explanation for its neurotoxicity via mass spectrometric imaging. Xenobiotica 48:1\u20137. \n                    https:\/\/doi.org\/10.1080\/00498254.2017.1375168","journal-title":"Xenobiotica"},{"key":"9826_CR20","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1088\/0031-9155\/45\/7\/322","volume":"45","author":"R Ott","year":"2000","unstructured":"Ott R, MacDonald J, Wells KJPiM (2000) The performance of a CCD digital autoradiography imaging system. Phys Med Biol 45:2011","journal-title":"Phys Med Biol"},{"key":"9826_CR21","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.1039\/C8RA00984H","volume":"8","author":"A Pamreddy","year":"2018","unstructured":"Pamreddy A, Baijnath S, Naicker T, Ntshangase S, Mdanda S, Lubanyana H, Kruger HG, Govender T (2018) Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system. RSC Adv 8:11902\u201311907. \n                    https:\/\/doi.org\/10.1039\/C8RA00984H","journal-title":"RSC Adv"},{"key":"9826_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1086\/383572","volume":"38","author":"J-J Parienti","year":"2004","unstructured":"Parienti J-J, Massari V, Descamps D, Vabret A, Bouvet E, Larouz\u00e9 B, Verdon R (2004) Predictors of virologic failure and resistance in hiv-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis 38:1311\u20131316. \n                    https:\/\/doi.org\/10.1086\/383572","journal-title":"Clin Infect Dis"},{"key":"9826_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jchromb.2016.05.040","volume":"1027","author":"SD Penchala","year":"2016","unstructured":"Penchala SD, Fawcett S, Else L, Egan D, Amara A, Elliot E, Challenger E, Back D et al (2016) The development and application of a novel LC\u2013MS\/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. J Chromatogr B 1027:174\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2016.05.040","journal-title":"J Chromatogr B"},{"key":"9826_CR24","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1016\/j.jprot.2012.07.028","volume":"75","author":"B Prideaux","year":"2012","unstructured":"Prideaux B, Stoeckli M (2012) Mass spectrometry imaging for drug distribution studies. J Proteom 75:4999\u20135013. \n                    https:\/\/doi.org\/10.1016\/j.jprot.2012.07.028","journal-title":"J Proteom"},{"key":"9826_CR25","first-page":"5618s","volume":"50","author":"RM Ruprecht","year":"1990","unstructured":"Ruprecht RM, Bernard LD, Chou T-C, Sosa MAG, Fazely F, Koch J, Sharma PL, Mullaney SJCr (1990) Murine models for evaluating antiretroviral therapy. Cancer Res 50:5618s\u20135627s","journal-title":"Cancer Res"},{"key":"9826_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2152\/jmi.60.35","volume":"60","author":"M Shibata","year":"2013","unstructured":"Shibata M, Takahashi M, Yoshino M, Kuwahara T, Nomura T, Yokomaku Y, Sugiura W (2013) Development and application of a simple LC\u2013MS method for the determination of plasma rilpivirine (TMC-278) concentrations. J Med Invest 60:35\u201340. \n                    https:\/\/doi.org\/10.2152\/jmi.60.35","journal-title":"J Med Invest"},{"key":"9826_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/adt.2015.634","volume":"13","author":"A Shobo","year":"2015","unstructured":"Shobo A, Bratkowska D, Baijnath S, Naiker S, Bester LA, Singh SD, Maguire GEM, Kruger HG et al (2015) Visualization of time-dependent distribution of rifampicin in rat brain using MALDI MSI and quantitative LCMS\/MS. Assay Drug Dev Technol 13:277\u2013284. \n                    https:\/\/doi.org\/10.1089\/adt.2015.634","journal-title":"Assay Drug Dev Technol"},{"key":"9826_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/jhep.2002.30319","volume":"35","author":"MS Sulkowski","year":"2003","unstructured":"Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD (2003) Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35:182\u2013189. \n                    https:\/\/doi.org\/10.1053\/jhep.2002.30319","journal-title":"Hepatology"},{"key":"9826_CR29","doi-asserted-by":"publisher","first-page":"15647","DOI":"10.1073\/pnas.0502548102","volume":"102","author":"PM Thompson","year":"2005","unstructured":"Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT (2005) Thinning of the cerebral cortex visualized in HIV\/AIDS reflects CD4\u2009+\u2009T lymphocyte decline. Proc Natl Acad Sci USA 102:15647. \n                    https:\/\/doi.org\/10.1073\/pnas.0502548102","journal-title":"Proc Natl Acad Sci USA"},{"key":"9826_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.16.1.18567","volume":"16","author":"I Usach","year":"2013","unstructured":"Usach I, Melis V, Peris J-E (2013) Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability. J Int AIDS Soc 16:1\u201314. \n                    https:\/\/doi.org\/10.7448\/ias.16.1.18567","journal-title":"J Int AIDS Soc"},{"key":"9826_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00227766","volume":"85","author":"S Weis","year":"1993","unstructured":"Weis S, Haug H, Budka H (1993) Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol 85:185\u2013189. \n                    https:\/\/doi.org\/10.1007\/bf00227766","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-019-09826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10735-019-09826-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-019-09826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:08:06Z","timestamp":1587424086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10735-019-09826-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9826"],"URL":"https:\/\/doi.org\/10.1007\/s10735-019-09826-y","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}